- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Buy the Dip
Global Pharmaceuticals & Biotech Buy the Dip
UPDATED Apr 21, 2024
Companies which may present a buying opportunity after a dip in share price.
212 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RVNC | US$3.78 | -4.8% | -88.0% | US$393.9m | US$16.33 | PS1.7x | E67.8% | n/a | ||
PHO | kr54.80 | -2.0% | 2.0% | kr1.5b | kr86.00 | PE5563.3x | E88.3% | 0% | ||
301080 | CN¥36.49 | -1.0% | -46.7% | CN¥4.3b | CN¥80.78 | PE26.4x | E28.6% | 2.7% | ||
MIRM | US$23.81 | -0.4% | -12.8% | US$1.1b | US$48.91 | PS6x | E65.6% | n/a | ||
ESPR | US$1.95 | 0.8% | 59.8% | US$369.3m | US$7.41 | PS3.2x | E59.2% | n/a | ||
MITRA | €0.22 | -2.6% | -92.4% | €15.5m | n/a | PE-0.09x | E105.1% | 0% | ||
GBT | US$68.49 | 0.6% | 169.5% | US$4.6b | US$68.50 | PS19.7x | E66.2% | n/a | ||
ARCT | US$25.98 | -11.4% | -8.8% | US$699.3m | US$67.89 | PS4.2x | E60.0% | n/a | ||
MSB | AU$0.80 | -4.2% | -19.7% | AU$907.3m | AU$1.10 | PS78.2x | E64.4% | n/a | ||
PCRX | US$26.25 | -1.1% | -42.7% | US$1.2b | US$45.73 | PE29.1x | E29.3% | n/a | ||
TLRY | US$1.73 | -2.8% | -26.4% | US$1.3b | US$2.37 | PS1.8x | E86.1% | n/a | ||
AMPH | US$40.01 | -1.9% | -2.2% | US$2.0b | US$62.60 | PE14.2x | E19.7% | n/a | ||
CDXC | US$3.69 | -6.1% | 169.3% | US$278.5m | US$6.08 | PS3.3x | E93.2% | n/a | ||
ICPT | US$19.00 | 0.1% | 19.1% | US$794.7m | US$19.00 | PS2.5x | E42.4% | n/a | ||
A214450 | ₩129,500.00 | 2.9% | 29.8% | ₩1.3t | ₩175,000.00 | PE17.3x | E20.5% | 0.7% | ||
2395 | JP¥1,433.00 | -3.1% | -42.0% | JP¥59.2b | JP¥3,150.00 | PE10.8x | E18.3% | 3.5% | ||
IRWD | US$7.92 | 1.7% | -25.1% | US$1.2b | US$17.40 | PS2.8x | E67.9% | n/a | ||
XERS | US$1.74 | -5.9% | -24.0% | US$244.4m | US$4.75 | PS1.5x | E62.1% | n/a | ||
BCRX | US$4.43 | -5.1% | -41.8% | US$913.2m | US$12.20 | PS2.8x | E64.1% | n/a | ||
MDP | CA$1.65 | 5.8% | 19.6% | CA$40.4m | CA$3.21 | PE5x | E46.9% | n/a | ||
BGNE | US$129.52 | -6.4% | -49.7% | US$13.5b | US$268.64 | PS5.5x | E56.2% | n/a | ||
AMRN | US$0.86 | -6.5% | -34.9% | US$352.9m | US$1.08 | PS1.1x | E51.1% | n/a | ||
EVT | €13.26 | -3.8% | -25.4% | €2.4b | €25.40 | PS2.9x | E57.9% | n/a | ||
ALPAT | €10.20 | -1.0% | -20.3% | €11.1m | €11.50 | PS4.7x | E92.7% | n/a |